In the treatment of Helicobacter pylori infection, combination therapies using the oral potassium-competitive acid blocker vonoprazan were superior to standard proton pump inhibitor (PPI)–based triple therapy, producing higher eradication rates, according to combined data from a U.S. and a European phase 3 randomized, controlled trial. Vonoprazan has been submitted to the Food and Drug Administration for approval […]
Home »
Could proton beam therapy improve throat cancer treatment?
From chemotherapy drugs that affect the whole body to very precise surgery to remove a tumor, different cancers require different treatments. One treatment that has been used for over a century is radiotherapy, which involves the use of high energy photons—such as X-rays or gamma rays. Rather than subjecting the entire body to treatment, this […]
Is proton therapy the silver bullet for children with brain cancer?
Adelaide is poised to open Australia’s first proton therapy center in 2025, with children and young adults expected to be the main beneficiaries of more effective cancer treatment with fewer side effects. But just how safe is proton therapy for children with brain cancer compared to the conventional X-ray radiation delivered post-surgery? A new study […]
Excess cause-specific mortality tied to chronic proton pump inhibitor use
(HealthDay)—Taking proton pump inhibitors (PPIs) is associated with an excess of cause-specific mortality, according to a study published online May 30 in The BMJ. Yan Xie, M.P.H., from St. Louis Health Care System, and colleagues conducted a longitudinal observational cohort study to estimate all-cause mortality and cause-specific mortality among patients taking PPIs. Data were included […]